Clinical trial
Phase 4 Study of Once-Daily Intramuscular Cefepime Versus Ceftriaxone for In-Home Treatment of Nursing Home-Acquired Pneumonia
NCT00358202 is registered in ClinicalTrials.gov with CPL Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 4 Study of Once-Daily Intramuscular Cefepime Versus Ceftriaxone for In-Home Treatment of Nursing Home-Acquired Pneumonia
- Lead sponsor
- CPL Associates
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2002
- Completion date
- April 30, 2006
- Enrollment
- 69 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.